Dr. Jonathan Engler Discusses the Dangers of mRNA Vaccines

He highlights the unpredictable antigen production and potential health risks due to lipid nanoparticles and contaminants. Engler argues that the term "vaccine" misleads the public and regulators about the safety and efficacy of these products.

00:24 - Dr. Jonathan Engler discusses the issues surrounding mRNA vaccines, highlighting that they are fundamentally different from traditional vaccines. He emphasizes the potential dangers associated with lipid nanoparticles in these vaccines.

- Engler underscores the misconception regarding vaccine safety, asserting that the mRNA technology poses inherent risks that were previously underestimated. This misunderstanding has led to misinformation about vaccine effectiveness.

- The mechanism of lipid nanoparticles is explained, showing how they deliver mRNA into cells, prompting an immune response that can inadvertently harm healthy cells throughout the body.

- Engler warns that multiple doses of the vaccine may exacerbate these issues, raising concerns about cumulative effects and unpredictable responses in the body over time.

02:19 - The discussion highlights significant concerns regarding the safety and effectiveness of COVID vaccines, emphasizing the potential dangers of improper dosage and contamination. This raises critical questions about the trustworthiness of vaccine labeling and regulation.

- The variability in vaccine dosages can cause severe health risks, paralleling the dangers of administering incorrect amounts of morphine. This unpredictability poses a serious threat to patient safety.

- Dr. Engler's role in advocating for victims of vaccine-related injuries is crucial, as he helps raise awareness about the growing number of affected individuals. His insights shed light on the ongoing issues surrounding vaccine safety.

- The traditional perception of vaccines as safe medical solutions is challenged, highlighting that current products may differ significantly from historical vaccines. This distinction has serious implications for public health trust.

04:37 - Public perception of vaccines, particularly the Pfizer vaccine, has been shaped by assumptions about safety and efficacy, leading to widespread acceptance despite limited testing. This situation raises significant concerns regarding regulatory standards and the novel mRNA technology used.

- The lack of rigorous testing for the Pfizer vaccine contrasts sharply with traditional drug approval processes, creating questions about safety and efficacy. This disparity has surprised even the manufacturers involved.

- The mRNA lipid nanoparticle platform used in the vaccine is a novel technology, previously only tested in limited cancer trials, raising safety concerns. Early findings indicated the potential toxicity of repeated doses.

- The fundamental design of vaccines traditionally introduces a harmless virus to train the immune system. However, the mRNA approach represents a significant shift in vaccine development and public health strategy.

06:55 - The use of mRNA vaccines introduces a spike protein that triggers the immune system, but the uncontrolled production of antigens poses significant health risks. Issues like inflammation and contamination complicate the safety of these vaccines.

- The unpredictability of antigen production varies greatly among individuals, raising concerns about dosages that could be thousands of times different than intended. This variability can affect vaccine efficacy.

- The spike protein is engineered to linger longer in the body, potentially leading to adverse effects and inflammation. This extended presence raises questions about long-term safety.

         

- Contaminants like DNA and endotoxins found in the vaccine manufacturing process could contribute to inflammation and other health issues. These factors necessitate stricter quality control in vaccine production.